TABLE 2.
Single and double point mutations in the context of Mini-RAG1
| Position and mutationa | Amino acidb | Protein yieldc | RAG2 bindingd | |
|---|---|---|---|---|
| 1 | 524D | Lys | ++++ | + |
| 2 | 531K | Asp | ++++ | ++ |
| 3 | 541N | Leu | ++++ | + |
| 4 | 546N | Asp | ++++ | − |
| 5 | 547Q | Gln | ++++ | − |
| 6 | 551K | Asp | ++++ | ++ |
| 7 | 997Q | Lys | ++++ | − |
| 8 | 997E | Lys | ++++ | + |
| 9 | 1001E | Lys | ++++ | ++ |
| 10 | S517N/S519N | Phe-Trp | − | NDe |
| 11 | N529S/N530A | Arg-Thr | ++++ | + |
| 12 | Lys-546/Lys-547 | Asp-Glu | ++++ | − |
| 13 | Asn-536/Gln-Q547 | Asp-Glu | ++++ | − |
a All mutants were N-terminal MBP- and C-terminal His6-tagged.
b These are the residue(s) mutated.
c Protein yield and quality were evaluated by FPLC. ++++, expression typical for MBP-Mini-RAG1, which is ∼5-fold greater than that of MBP-R1c; −, no protein expression detected.
d The ability to bind to GST-RAG2 core was tested by BLItz. ++, binding as seen between R2c and either R1c or Mini-RAG1; +, binding reduced 3–20 fold; −, little or no binding detected.
e ND means not done.